{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T11:20:58Z","timestamp":1715599258303},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.vph.2004.03.001","type":"journal-article","created":{"date-parts":[[2004,5,11]],"date-time":"2004-05-11T13:11:27Z","timestamp":1084281087000},"page":"7-13","source":"Crossref","is-referenced-by-count":7,"title":["Effects of R-102444, an orally active 5-HT2A receptor antagonist, in rat models of peripheral vascular disease"],"prefix":"10.1016","volume":"41","author":[{"given":"Taketoshi","family":"Ogawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhiro","family":"Sugidachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumitoshi","family":"Asai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2004.03.001_BIB1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0049-3848(80)90170-X","article-title":"Protective effect of ticlopidine on experimentally induced peripheral arterial occlusive disease in rats","volume":"18","author":"Ashida","year":"1980","journal-title":"Thromb. Res."},{"key":"10.1016\/j.vph.2004.03.001_BIB2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0308-2261(18)30026-2","article-title":"Diabetes mellitus, vascular disease and thrombosis","volume":"15","author":"Banga","year":"1986","journal-title":"Clin. Haematol."},{"key":"10.1016\/j.vph.2004.03.001_BIB3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2362.1988.tb01030.x","article-title":"Intraplatelet serotonin in patients with diabetes mellitus and peripheral vascular disease","volume":"18","author":"Barradas","year":"1988","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.vph.2004.03.001_BIB4","first-page":"202","article-title":"LY215840, a potent 5-hydroxytryptamine (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2 receptors and delays occlusion in a rabbit model of thrombosis","volume":"261","author":"Cohen","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.vph.2004.03.001_BIB5","first-page":"228","article-title":"5-hydroxytryptamine and platelet aggregation","volume":"42","author":"De Clerck","year":"1983","journal-title":"Fed. Proc."},{"key":"10.1016\/j.vph.2004.03.001_BIB6","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/BF01965409","article-title":"Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist","volume":"12","author":"De Clerck","year":"1982","journal-title":"Agents Actions"},{"issue":"Suppl. 1","key":"10.1016\/j.vph.2004.03.001_BIB7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2165\/00003495-198800361-00015","article-title":"Hyperreactivity of platelets to serotonin (5-hydroxytryptamine) in patients with cardiovascular diseases. Influence of ketanserin, a serotonin S2-receptor antagonist","volume":"36","author":"De Cree","year":"1988","journal-title":"Drugs"},{"key":"10.1016\/j.vph.2004.03.001_BIB8","first-page":"616","article-title":"Effect of (+\/\u2212)-2-(dimethylamino)-1-[[o-(m-methoxyphenethyl)phenoxy] methyl]ethyl hydrogen succinate on experimental models of peripheral obstructive disease","volume":"41","author":"Hara","year":"1991","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.vph.2004.03.001_BIB9","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJM200105243442108","article-title":"Medical treatment of peripheral arterial disease and claudication","volume":"344","author":"Hiatt","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2004.03.001_BIB10","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.286.11.1317","article-title":"Peripheral arterial disease detection, awareness, and treatment in primary care","volume":"286","author":"Hirsch","year":"2001","journal-title":"JAMA"},{"issue":"Suppl. 3","key":"10.1016\/j.vph.2004.03.001_BIB11","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1097\/00005344-199400233-00010","article-title":"Naftidrofuryl in intermittent claudication: a retrospective analysis","volume":"23","author":"Lehert","year":"1994","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"Suppl. 82","key":"10.1016\/j.vph.2004.03.001_BIB12","first-page":"1","article-title":"Vasodilator drugs against experimental peripheral gangrene; a method of testing the effect of vasodilator drugs on constricted peripheral vessels","volume":"23","author":"Lund","year":"1951","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.vph.2004.03.001_BIB13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0090-6980(95)00005-U","article-title":"Effect of TFC-612, a 7-thia prostaglandin E1 derivative, on a peripheral arterial occlusive disease model in rats","volume":"49","author":"Motoyama","year":"1995","journal-title":"Prostaglandins"},{"key":"10.1016\/j.vph.2004.03.001_BIB14","first-page":"991","article-title":"Effect of isocarbacyclin methyl ester incorporated in lipid microspheres on experimental models of peripheral obstructive disease","volume":"45","author":"Murakami","year":"1995","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.vph.2004.03.001_BIB15","first-page":"856","article-title":"Effect of beraprost sodium on peripheral circulation insufficiency in rats and rabbits","volume":"39","author":"Murai","year":"1989","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.vph.2004.03.001_BIB16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-2999(02)02654-7","article-title":"Pharmacological profiles of R-96544, the active form of a novel 5-HT2Areceptor antagonist R-102444","volume":"457","author":"Ogawa","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.vph.2004.03.001_BIB17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0026-2862(86)90048-8","article-title":"Specific increase in sensitivity to serotonin of the canine hindlimb collateral arterial tree via the 5-hydroxytryptamine-2 receptor","volume":"32","author":"Orlandi","year":"1986","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.vph.2004.03.001_BIB18","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1161\/01.CIR.80.6.1544","article-title":"Randomized placebo-controlled, double-blind trial of ketanserin in claudicants: changes in claudication distance and ankle systolic pressure","volume":"80","author":"PACK Claudication Substudy","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2004.03.001_BIB19","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/bmj.298.6671.424","article-title":"Prevention of atherosclerotic complications: controlled trial of ketanserin","volume":"298","author":"Prevention of Atherosclerotic Complications with Ketanserin Trial Group","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.vph.2004.03.001_BIB20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0049-3848(95)00212-X","article-title":"Quantitative measurement of various 5-HT receptor antagonists on platelet activation induced by serotonin","volume":"81","author":"Qi","year":"1996","journal-title":"Thromb. Res."},{"key":"10.1016\/j.vph.2004.03.001_BIB21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0049-3848(96)00212-5","article-title":"The effect of a 5HT2 receptor antagonist sarpogrelate (MCI-9042) treatment on platelet function in Buerger's disease","volume":"84","author":"Rydzewski","year":"1996","journal-title":"Thromb. Res."},{"key":"10.1016\/j.vph.2004.03.001_BIB22","doi-asserted-by":"crossref","first-page":"3D","DOI":"10.1016\/S0002-9149(01)01671-X","article-title":"Intermittent claudication: magnitude of the problem, patient evaluation, and therapeutic strategies","volume":"87","author":"Schmieder","year":"2001","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.vph.2004.03.001_BIB23","first-page":"1475","article-title":"Inhibition of serotonin-induced vascular smooth muscle cell proliferation by sarpogrelate","volume":"290","author":"Sharma","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.vph.2004.03.001_BIB24","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1161\/01.CIR.82.6.1925","article-title":"Intermittent claudication, heart disease risk factors, and mortality: The Whitehall Study","volume":"82","author":"Smith","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2004.03.001_BIB25","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1248\/cpb.48.1729","article-title":"[2-(\u03c9-Phenylalkyl)phenoxy]alkylamines: III. Synthesis and selective serotonin-2 receptor binding (2)","volume":"48","author":"Tanaka","year":"2000","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.vph.2004.03.001_BIB26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/s-2007-1005050","article-title":"Platelet consumption in cardiovascular disease","volume":"8","author":"Turpie","year":"1982","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.vph.2004.03.001_BIB27","first-page":"182","article-title":"Antihypertensive properties of ketanserin (R 41 468)","volume":"42","author":"Vanhoutte","year":"1983","journal-title":"Fed. Proc."},{"key":"10.1016\/j.vph.2004.03.001_BIB28","first-page":"280","article-title":"Serotonin-induced blood flow changes in the rat hindlegs after unilateral ligation of the femoral artery. Inhibition by the S2 receptor antagonist ketanserin","volume":"270","author":"Verheyen","year":"1984","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.vph.2004.03.001_BIB29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1254\/jjp.59.57","article-title":"Inhibitory effect of OP-41483.alpha-CD, a prostacyclin analog, on peripheral vascular lesion models in rats","volume":"59","author":"Wakitani","year":"1992","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.vph.2004.03.001_BIB30","first-page":"760","article-title":"Effects of naftidrofuryl on adrenergic nerves, endothelium and smooth muscle in isolated canine blood vessels","volume":"239","author":"Zander","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.vph.2004.03.001_BIB31","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/0002-9149(89)90051-9","article-title":"Incidence and clinical relevance of QT prolongation caused by the new selective serotonin antagonist ketanserin","volume":"63","author":"Zehender","year":"1989","journal-title":"Am. J. Cardiol."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189104000540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189104000540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T13:11:08Z","timestamp":1623935468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189104000540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S1537189104000540"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2004.03.001","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}